Virtu Financial’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
4,694
+908
+24% +$62.4K 0.01% 680
2026
Q1
$242K Buy
+3,786
New +$263K 0.01% 925
2025
Q1
Sell
-4,875
Closed -$309K 1679
2024
Q4
$309K Buy
+4,875
New +$282K 0.02% 687
2024
Q1
Sell
-13,802
Closed -$797K 1727
2023
Q4
$797K Buy
+13,802
New +$707K 0.06% 258
2022
Q3
Sell
-684
Closed -$35K 1955
2022
Q2
$35K Buy
+684
New +$30.3K ﹤0.01% 1213

Other funds holding IRON

Virtu Financial's IRON Position: Q2 2026 in Review

Virtu Financial increased its Disc Medicine (IRON) stake by 24% in Q2 2026, buying an estimated $62.4K and bringing the position to 4,694 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #680.

Virtu Financial first reported a position in IRON in Q2 2022 and has held it in 5 quarters since. The position peaked at $797K in Q4 2023. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Virtu Financial held 4,694 shares of Disc Medicine worth $343K as of Q2 2026.
  • Virtu Financial bought 908 Disc Medicine shares in Q2 2026, an estimated $62.4K.
  • Disc Medicine made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #680 holding.
  • Virtu Financial first reported a position in Disc Medicine in Q2 2022 and has held it in 5 quarters since.
  • Virtu Financial's Disc Medicine position peaked at $797K in Q4 2023.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.